Abstract:Objective To investigate the inhibition effects of CpG oligodeoxynucleotide(CpG ODN) on renal carcinoma cell proliferation and tumor growth in vivo and in vitro,and explore the possible mechanism.Methods The effects of different concentrations of CpG ODN1826 and non-CpG ODN1982(ODN1982) interventions on proliferation of human renal clear cell carcinoma cell line Caki-1 cultured in vitro were determined with CCK-8 method.Tumor-bearing nude mouse models were established by subcutaneous implantation of Caki-1 cells into 24 BALB/c mice,and were randomly divided into control group(PBS),ODN1982 group(50 μg ODN1982),low-dose CpG ODN1826 group(25 μg CpG ODN1826) and high-dose CpG ODN1826 group(50 μg CpG ODN1826) 4 d later according to means of weekly treatment,with 6 mice in each group.Mice were sacrificed 35 d after model establishment,and changes of tumor volumes,tumor weight and tumor histology were compared among groups.Splenic lymphocytes of tumor-bearing mice in each group were isolated in vitro,and lactate dehydrogenase release method was employed to detect the cytolytic activity of splenic lymphocytes of tumor-bearing mice to tumor cells with different effector/target ratios(splenic lymphocytes:Caki-1 cells or splenic lymphocytes:YAC-1 cells).Results ODN1982 had no significant effect on in vitro proliferation of Caki-1 cells,while 500 μg/mL CpG ODN1826 significantly inhibited proliferation of Caki-1 cells.The tumor volumes of low-dose CpG ODN1826 group and high-dose CpG ODN1826 group were significantly smaller than those of control group and ODN1982 group at the end point of experiment(P 0.05),and there were significant differences in tumor weight among groups(P 0.05).It was revealed by histological observations that there were more inflammatory cell infiltration in low-dose CpG ODN1826 group and high-dose CpG ODN1826 group.The cytolytic activity of splenic lymphocytes of mice in high-dose CpG ODN1826 group to Caki-1 cells and YAC-1 cells was(9.74 ± 1.16) % and(79.65 ± 5.23) %,respectively at effector/target ratio of 50:1,and was significantly higher than that in control group [(7.67 ± 0.22) % and(10.12 ± 3.03) %,respectively] and ODN1982 group [(7.66 ± 0.93) % and(27.60 ± 9.83) %,respectively](P 0.05).Conclusion CpG ODN can inhibit renal carcinoma cell proliferation in vitro and tumor growth in tumor-bearing nude mice,and the mechanism may relate to the enhancement of innate immunity by CpG ODN.

The inhibitory effect of c-myc antisense oligodeoxynucleotide on the growth of renal carcinoma cell and effect on cell cycle

Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.

EFFECTS OF DIFFERENT CONCENTRATIONS OF ANTISENSE OLIGODEOXYNUCLEOTIDES(ASODN) ON HUMAN PANCREATIC CANCER CELL LINE PaTu8988s

[Adenovirus Mediated Antisense C-Myc Gene on the Chemotherapy Sensitivity of Osteosarcoma Cells to Cisplatin].

Construction of Antisense c-myc Recombinant Adenovirus and Its Anti-tumor Effects on Osteosarcoma Cell Lines MG-63 and U2OS

Antisense C - Myc Sensitizes Osteosarcoma Cells to Cisplatin- Induced Apoptosis

Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.

Effect of K‐ras Antisense Oligodeoxynucleotides on Human Pancreatic Cancer Cell Line PaTu 8988S

Biological effects of liposome-mediated c-myc antisense oligodeoxynucleotide on human hepatoma cells

Preliminary Study on the Mechanism of C-myc Antisense Oligodexynucleotide Against Malignant Melanoma Cells

The effect of antisense c-myc by liposomes on the growth of human hepatoma in nude mice

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

In Vivo and in Vitro Study of Inhibition Effects of CpG Oligodeoxynucleotide on Renal Carcinoma Cell Proliferation and Tumor Growth

[Knockdown of Cyclin A2 Expression by Small Interfering RNA in MG-63 Cells].

[Growth Inhibition of MG-63 Cells by Cyclin A2 Gene-Specific Small Interfering RNA].

Antisense Oligonucleotide Inhibits the Growth of Human Melanoma Cells and Influences Its Cycle

Effect of antisense oligodeoxynucelotide specific to ki-Ras gene on human gastric carcinoma cells and human vascular endothelial cells

[Effects of Vascular Endothelial Growth Factor (VEGF) Antisense Oligodeoxynucleotide on Mrna and Expression of VEGF, Flt-1, and Kinase Insert Domain Containing Receptor and VEGF Excretion in Human Gallbladder Carcinoma Cells].

Inhibition of antisense oligonucleotides on EGFR expression and proliferation of RPE cell in vivo

Effect of Human Telomerase Antisense Oligodeoxyribonucleotides on the Growth Inhibition of Gastric Cancer Cell Lines with Well, Moderate and Poor Differentiation

Inhibitory Effect of Ornithine Decarboxylase and S-Adenosylmethionine Decarboxylase Biantisense Adenovirus on Colorectal Cancer Cells